Huber Capital Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,520
| Closed | -$843K | – | 92 |
|
|
2022
Q3 | $843K | Sell |
10,520
-4,000
| -28% | -$377K | 0.24% | 64 |
|
|
2022
Q2 | $1.39M | Hold |
14,520
| – | – | 0.39% | 51 |
|
|
2022
Q1 | $2.16M | Hold |
14,520
| – | – | 0.53% | 51 |
|
|
2021
Q4 | $2.06M | Sell |
14,520
-2,000
| -12% | -$283K | 0.54% | 49 |
|
|
2021
Q3 | $2.16M | Sell |
16,520
-1,700
| -9% | -$222K | 0.56% | 49 |
|
|
2021
Q2 | $2.5M | Sell |
18,220
-300
| -2% | -$41.1K | 0.64% | 47 |
|
|
2021
Q1 | $2.42M | Sell |
18,520
-100
| -0.5% | -$12K | 0.65% | 46 |
|
|
2020
Q4 | $2.08M | Sell |
18,620
-8,631
| -32% | -$817K | 0.68% | 40 |
|
|
2020
Q3 | $2.14M | Hold |
27,251
| – | – | 0.79% | 36 |
|
|
2020
Q2 | $1.96M | Hold |
27,251
| – | – | 0.4% | 47 |
|
|
2020
Q1 | $1.56M | Buy |
27,251
+1,300
| +5% | +$120K | 0.29% | 58 |
|
|
2019
Q4 | $2.9M | Sell |
25,951
-5,904
| -19% | -$629K | 0.38% | 55 |
|
|
2019
Q3 | $3.06M | Sell |
31,855
-13,027
| -29% | -$1.22M | 0.38% | 60 |
|
|
2019
Q2 | $3.84M | Sell |
44,882
-2,700
| -6% | -$222K | 0.46% | 54 |
|
|
2019
Q1 | $3.96M | Sell |
47,582
-61,114
| -56% | -$4.44M | 0.42% | 58 |
|
|
2018
Q4 | $6.98M | Sell |
108,696
-22,770
| -17% | -$1.56M | 0.64% | 52 |
|
|
2018
Q3 | $10.4M | Sell |
131,466
-10,338
| -7% | -$800K | 0.67% | 55 |
|
|
2018
Q2 | $10.4M | Sell |
141,804
-25,176
| -15% | -$1.71M | 0.67% | 55 |
|
|
2018
Q1 | $10.6M | Sell |
166,980
-9,754
| -6% | -$582K | 0.62% | 58 |
|
|
2017
Q4 | $9.01M | Sell |
176,734
-8,600
| -5% | -$448K | 0.49% | 60 |
|
|
2017
Q3 | $9.72M | Sell |
185,334
-3,500
| -2% | -$176K | 0.53% | 60 |
|
|
2017
Q2 | $9.62M | Hold |
188,834
| – | – | 0.49% | 62 |
|
|
2017
Q1 | $8.39M | Sell |
188,834
-197,533
| -51% | -$8.5M | 0.43% | 63 |
|
|
2016
Q4 | $17.1M | Buy |
386,367
+3,870
| +1% | +$164K | 0.66% | 52 |
|
|
2016
Q3 | $15.3M | Buy |
382,497
+32,000
| +9% | +$1.36M | 0.6% | 52 |
|
|
2016
Q2 | $16.7M | Buy |
350,497
+9,664
| +3% | +$409K | 0.69% | 51 |
|
|
2016
Q1 | $14.3M | Buy |
340,833
+173,907
| +104% | +$6.83M | 0.57% | 55 |
|
|
2015
Q4 | $7.35M | Sell |
166,926
-300
| -0.2% | -$13K | 0.26% | 68 |
|
|
2015
Q3 | $7.98M | Buy |
167,226
+12,726
| +8% | +$699K | 0.28% | 70 |
|
|
2015
Q2 | $9M | Buy |
154,500
+121,500
| +368% | +$6.55M | 0.26% | 74 |
|
|
2015
Q1 | $1.67M | Buy |
+33,000
| New | +$1.62M | 0.05% | 91 |
|
Other funds holding CNMD
CIP
Huber Capital Management's CNMD Position: Q4 2022 in Review
Huber Capital Management sold out of CONMED (CNMD) in Q4 2022, closing a stake of 10,520 shares — an estimated $843K sold.
Huber Capital Management first reported a position in CNMD in Q1 2015 and held it in 31 quarters. The position peaked at $17.1M in Q4 2016. 239 funds tracked by Wall St. Rank hold CNMD as of Q4 2022.
- Huber Capital Management reported no remaining CONMED position as of Q4 2022 after selling out during the quarter.
- Huber Capital Management sold 10,520 CONMED shares in Q4 2022, an estimated $843K.
- Huber Capital Management first reported a position in CONMED in Q1 2015 and held it in 31 quarters.
- Huber Capital Management's CONMED position peaked at $17.1M in Q4 2016.
- 239 funds tracked by Wall St. Rank held CONMED as of Q4 2022.
Based on Huber Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.